Charles Schwab’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
381,337
+19,802
| +5% | +$89.3K | ﹤0.01% | 2716 |
|
|
2025
Q1 | $1.68M | Sell |
361,535
-8,937
| -2% | -$41.5K | ﹤0.01% | 2671 |
|
|
2024
Q4 | $2.57M | Buy |
370,472
+23,974
| +7% | +$166K | ﹤0.01% | 2603 |
|
|
2024
Q3 | $1.84M | Buy |
346,498
+34,698
| +11% | +$184K | ﹤0.01% | 2733 |
|
|
2024
Q2 | $1.17M | Buy |
311,800
+61,218
| +24% | +$229K | ﹤0.01% | 2873 |
|
|
2024
Q1 | $1.77M | Buy |
250,582
+5,020
| +2% | +$35.4K | ﹤0.01% | 2628 |
|
|
2023
Q4 | $1.39M | Buy |
245,562
+3,069
| +1% | +$17.3K | ﹤0.01% | 2722 |
|
|
2023
Q3 | $1.16M | Buy |
242,493
+12,275
| +5% | +$58.8K | ﹤0.01% | 2752 |
|
|
2023
Q2 | $1.58M | Buy |
230,218
+5,832
| +3% | +$39.9K | ﹤0.01% | 2628 |
|
|
2023
Q1 | $1.75M | Sell |
224,386
-98
| -0% | -$763 | ﹤0.01% | 2561 |
|
|
2022
Q4 | $1.71M | Buy |
224,484
+11,269
| +5% | +$85.8K | ﹤0.01% | 2616 |
|
|
2022
Q3 | $1.74M | Buy |
213,215
+96,981
| +83% | +$792K | ﹤0.01% | 2618 |
|
|
2022
Q2 | $1.12M | Sell |
116,234
-9,166
| -7% | -$88.6K | ﹤0.01% | 2744 |
|
|
2022
Q1 | $1.76M | Buy |
125,400
+40,338
| +47% | +$566K | ﹤0.01% | 2688 |
|
|
2021
Q4 | $1.74M | Buy |
85,062
+5,088
| +6% | +$104K | ﹤0.01% | 2742 |
|
|
2021
Q3 | $1.78M | Buy |
+79,974
| New | +$1.78M | ﹤0.01% | 2724 |
|